Cluster analysis of cognitive deficits may mark heterogeneity in schizophrenia in terms of outcome and response to treatment

European Archives of Psychiatry and Clinical Neuroscience

Volumn 264, Issue 4, 2014, Pages 333-343

  Gilbert, Elsa ^a   Mérette, Chantal ^a,b   Jomphe, Valérie ^a   Émond, Claudia ^a   Rouleau, Nancie ^a,b   Bouchard, Roch Hugo ^a   Roy, Marc André ^a,b   Paccalet, Thomas ^a   Maziade, Michel ^a,b  

^a CENTRE DE RECHERCHE DE L INSTITUT UNIVERSITAIRE EN SANTÉ MENTALE DE QUÉBEC   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

Cognitive profiles; Functioning; Heterogeneity; Response to treatment; Schizophrenia

Indexed keywords

NEUROLEPTIC AGENT; OLANZAPINE;

ADULT; ARTICLE; CLUSTER ANALYSIS; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; EPISODIC MEMORY; EXECUTIVE FUNCTION; FEMALE; GLOBAL ASSESSMENT OF FUNCTIONING; HUMAN; LIFESPAN; MAJOR CLINICAL STUDY; MALE; MENTAL PATIENT; MOTOR COORDINATION; NEUROPSYCHOLOGICAL TEST; PLANNING; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; PROBLEM SOLVING; PROCESSING; SCHIZOPHRENIA; SELECTIVE ATTENTION; SOCIAL STATUS; SYMPTOM; TREATMENT OUTCOME; TREATMENT RESPONSE; VELOCITY; WORKING MEMORY; ATTENTION; COGNITION DISORDERS; COMPLICATION; MIDDLE AGED; PSYCHOLOGICAL RATING SCALE; PSYCHOMOTOR PERFORMANCE; YOUNG ADULT;

ADULT; ANTIPSYCHOTIC AGENTS; ATTENTION; CLUSTER ANALYSIS; COGNITION DISORDERS; EXECUTIVE FUNCTION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMOTOR PERFORMANCE; SCHIZOPHRENIA; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84903610768     PISSN: 09401334     EISSN: 14338491     Source Type: Journal    
DOI: 10.1007/s00406-013-0463-7     Document Type: Article

References (68)

1. Perlis RH (2011) Translating biomarkers to clinical practice. Mol Psychiatry 16:1076-1087
2. Keshavan MS, Nasrallah HA, Tandon R (2011) Schizophrenia, "just the facts" 6. Moving ahead with the schizophrenia concept: from the elephant to the mouse. Schizophr Res 127:3-13
3. Levine SZ, Leucht S (2010) Elaboration on the early-onset hypothesis of antipsychotic drug action: treatment response trajectories. Biol Psychiatry 68:86-92
4. Levine SZ, Rabinowitz J (2010) Trajectories and antecedents of treatment response over time in early-episode psychosis. Schizophr Bull 36:624-632
5. Levine SZ, Rabinowitz J, Faries D, Lawson AH, Ascher-Svanum H (2012) Treatment response trajectories and antipsychotic medications: examination of up to 18 months of treatment in the CATIE chronic schizophrenia trial. Schizophr Res 137(1-3):141-146
6. Perkins DO, Gu H, Boteva K, Lieberman JA (2005) Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta-analysis. Am J Psychiatry 162:1785-1804 (Pubitemid 41428609)
7. Dickinson D, Gold JM (2008) Less unique variance than meets the eye: overlap among traditional neuropsychological dimensions in schizophrenia. Schizophr Bull 34:423-434
8. Green MF, Kern RS, Braff DL, Mintz J (2000) Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"? Schizophr Bull 26:119-136 (Pubitemid 30317696)
9. Green MF (1996) What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry 153:321-330
10. Fett AK, Viechtbauer W, Dominguez MD, Penn DL, van Os J, Krabbendam L (2011) The relationship between neurocognition and social cognition with functional outcomes in schizophrenia: a meta-analysis. Neurosci Biobehav Rev 35:573-588
11. Nuechterlein KH, Subotnik KL, Green MF, Ventura J, Asarnow RF, Gitlin MJ, Yee CM, Gretchen-Doorly D, Mintz J (2011) Neurocognitive predictors of work outcome in recent-onset schizophrenia. Schizophr Bull 37(Suppl 2):S33-S40
12. Milev P, Ho BC, Arndt S, Andreasen NC (2005) Predictive values of neurocognition and negative symptoms on functional outcome in schizophrenia: a longitudinal first-episode study with 7-year follow-up. Am J Psychiatry 162:495-506 (Pubitemid 40343916)
13. Bell MD, Johannesen JK, Greig TC, Wexler BE (2010) Memory profiles in schizophrenia: categorization validity and stability. Schizophr Res 118:26-33
14. Potter AI, Nestor PG (2010) Iq subtypes in schizophrenia: distinct symptom and neuropsychological profiles. J Nerv Ment Dis 198:580-585
15. Carrion RE, Goldberg TE, McLaughlin D, Auther AM, Correll CU, Cornblatt BA (2011) Impact of neurocognition on social and role functioning in individuals at clinical high risk for psychosis. Am J Psychiatry 168:806-813
16. Knowles EE, David AS, Reichenberg A (2010) Processing speed deficits in schizophrenia: reexamining the evidence. Am J Psychiatry 167:828-835
17. Allott K, Liu P, Proffitt TM, Killackey E (2011) Cognition at illness onset as a predictor of later functional outcome in early psychosis: systematic review and methodological critique. Schizophr Res 125:221-235
18. Wittorf A, Wiedemann G, Buchkremer G, Klingberg S (2008) Prediction of community outcome in schizophrenia 1 year after discharge from inpatient treatment. Eur Arch Psychiatry Clin Neurosci 258:48-58 (Pubitemid 351208249)
19. Wolwer W, Brinkmeyer J, Riesbeck M, Freimuller L, Klimke A, Wagner M, Moller HJ, Klingberg S, Gaebel W (2008) Neuropsychological impairments predict the clinical course in schizophrenia. Eur Arch Psychiatry Clin Neurosci 258(Suppl 5):28-34
20. Bell MD, Tsang HW, Greig T, Bryson G (2007) Cognitive predictors of symptom change for participants in vocational rehabilitation. Schizophr Res 96(1-3):162-168 (Pubitemid 47494648)
21. Seaton BE, Goldstein G, Allen DN (2001) Sources of heterogeneity in schizophrenia: the role of neuropsychological functioning. Neuropsychol Rev 11:45-67 (Pubitemid 33635921)
22. Basso MR, Nasrallah HA, Olson SC, Bornstein RA (1998) Neuropsychological correlates of negative, disorganized and psychotic symptoms in schizophrenia. Schizophr Res 31:99-111 (Pubitemid 28307950)
23. Rethelyi JM, Czobor P, Polgar P, Mersich B, Balint S, Jekkel E, Magyar K, Meszaros A, Fabian A, Bitter I (2012) General and domain-specific neurocognitive impairments in deficit and nondeficit schizophrenia. Eur Arch Psychiatry Clin Neurosci 262:107-115
24. Weickert TW, Goldberg TE, Gold JM, Bigelow LB, Egan MF, Weinberger DR (2000) Cognitive impairments in patients with schizophrenia displaying preserved and compromised intellect. Arch Gen Psychiatry 57:907-913
25. Kremen WS, Seidman LJ, Faraone SV, Toomey R, Tsuang MT (2000) The paradox of normal neuropsychological function in schizophrenia. J Abnorm Psychol 109:743-752 (Pubitemid 32096236)
26. Ilonen T, Taiminen T, Karlsson H, Lauerma H, Leinonen KM, Wallenius E, Salokangas RK (2004) Neuropsychological subtyping of schizophrenia. Psychiatry Res 129:191-199 (Pubitemid 39601815)
27. Hill SK, Ragland JD, Gur RC, Gur RE (2002) Neuropsychological profiles delineate distinct profiles of schizophrenia, an interaction between memory and executive function, and uneven distribution of clinical subtypes. J Clin Exp Neuropsychol 24:765-780 (Pubitemid 36042855)
28. Kremen WS, Seidman LJ, Faraone SV, Toomey R, Tsuang MT (2004) Heterogeneity of schizophrenia: a study of individual neuropsychological profiles. Schizophr Res 71:307-321 (Pubitemid 39330508)
29. Ammari N, Heinrichs RW, Miles AA (2010) An investigation of 3 neurocognitive subtypes in schizophrenia. Schizophr Res 121:32-38
30. Raffard S, Bayard S (2012) Understanding the executive functioning heterogeneity in schizophrenia. Brain Cogn 79:60-69
31. Fioravanti M, Bianchi V, Cinti ME (2012) Cognitive deficits in schizophrenia: an updated metanalysis of the scientific evidence. BMC Psychiatry 12:64
32. Mesholam-Gately RI, Giuliano AJ, Goff KP, Faraone SV, Seidman LJ (2009) Neurocognition in first-episode schizophrenia: a meta-analytic review. Neuropsychology 23:315-336
33. Maziade M, Rouleau N, Merette C, Cellard C, Battaglia M, Marino C, Jomphe V, Gilbert E, Achim A, Bouchard RH, Paccalet T, Paradis ME, Roy MA (2011) Verbal and visual memory impairments among young offspring and healthy adult relatives of patients with schizophrenia and bipolar disorder: selective generational patterns indicate different developmental trajectories. Schizophr Bull 37:1218-1228
34. Maziade M, Rouleau N, Gingras N, Boutin P, Paradis ME, Jomphe V, Boutin J, Letourneau K, Gilbert E, Lefebvre AA, Dore MC, Marino C, Battaglia M, Merette C, Roy MA (2009) Shared neurocognitive dysfunctions in young offspring at extreme risk for schizophrenia or bipolar disorder in eastern Quebec multigenerational families. Schizophr Bull 35:919-930
35. Cannon M, Caspi A, Moffitt TE, Harrington H, Taylor A, Murray RM, Poulton R (2002) Evidence for early-childhood, pan-developmental impairment specific to schizophreniform disorder: results from a longitudinal birth cohort. Arch Gen Psychiatry 59:449-456 (Pubitemid 34477681)
36. Niendam TA, Bearden CE, Rosso IM, Sanchez LE, Hadley T, Nuechterlein KH, Cannon TD (2003) A prospective study of childhood neurocognitive functioning in schizophrenic patients and their siblings. Am J Psychiatry 160:2060-2062 (Pubitemid 39619649)
37. Reichenberg A, Caspi A, Harrington H, Houts R, Keefe RS, Murray RM, Poulton R, Moffitt TE (2010) Static and dynamic cognitive deficits in childhood preceding adult schizophrenia: a 30-year study. Am J Psychiatry 167:160-169
38. Jones P, Rodgers B, Murray R, Marmot M (1994) Child development risk factors for adult schizophrenia in the British 1946 birth cohort. Lancet 344:1398-1402 (Pubitemid 24365314)
39. Osler M, Lawlor DA, Nordentoft M (2007) Cognitive function in childhood and early adulthood and hospital admission for schizophrenia and bipolar disorders in Danish men born in 1953. Schizophr Res 92:132-141 (Pubitemid 46561225)
40. Cannon TD, Bearden CE, Hollister JM, Rosso IM, Sanchez LE, Hadley T (2000) Childhood cognitive functioning in schizophrenia patients and their unaffected siblings: a prospective cohort study. Schizophr Bull 26:379-393 (Pubitemid 30423216)
41. Dickinson D, Goldberg TE, Gold JM, Elvevag B, Weinberger DR (2011) Cognitive factor structure and invariance in people with schizophrenia, their unaffected siblings, and controls. Schizophr Bull 37:1157-1167
42. Nuechterlein KH, Barch DM, Gold JM, Goldberg TE, Green MF, Heaton RK (2004) Identification of separable cognitive factors in schizophrenia. Schizophr Res 72:29-39 (Pubitemid 39452903)
43. Genderson MR, Dickinson D, Diaz-Asper CM, Egan MF, Weinberger DR, Goldberg TE (2007) Factor analysis of neurocognitive tests in a large sample of schizophrenic probands, their siblings, and healthy controls. Schizophr Res 94:231-239 (Pubitemid 47044871)
44. Nuechterlein KH, Green MF, Kern RS, Baade LE, Barch DM, Cohen JD, Essock S, Fenton WS, Frese FJ 3rd, Gold JM, Goldberg T, Heaton RK, Keefe RS, Kraemer H, Mesholam-Gately R, Seidman LJ, Stover E, Weinberger DR, Young AS, Zalcman S, Marder SR (2008) The matrics consensus cognitive battery, part 1: test selection, reliability, and validity. Am J Psychiatry 165:203-213 (Pubitemid 351704520)
45. Maziade M, Roy MA, Chagnon YC, Cliche D, Fournier JP, Montgrain N, Dion C, Lavallee JC, Garneau Y, Gingras N, Nicole L, Pires A, Ponton AM, Potvin A, Wallot H, Merette C (2005) Shared and specific susceptibility loci for schizophrenia and bipolar disorder: a dense genome scan in eastern Quebec families. Mol Psychiatry 10:486-499 (Pubitemid 40646437)
46. Maziade M, Roy MA, Fournier JP, Cliche D, Merette C, Caron C, Garneau Y, Montgrain N, Shriqui C, Dion C et al (1992) Reliability of best-estimate diagnosis in genetic linkage studies of major psychoses: results from the Quebec pedigree studies. Am J Psychiatry 149:1674-1686
47. Maziade M, Roy MA, Martinez M, Cliche D, Fournier JP, Garneau Y, Nicole L, Montgrain N, Dion C, Ponton AM (1995) Negative, psychoticism, and disorganized dimensions in patients with familial schizophrenia or bipolar disorder: continuity and discontinuity between the major psychoses. Am J Psychiatry 152:1458-1463
48. Roy MA, Lanctôt G, Mérette C, Cliche D, Fournier JP, Boutin P, Rodrigue C, Charron L, Turgeon M, Hamel M, Montgrain N, Nicole L, Pires A, Wallot H, Ponton AM, Garneau Y, Dion C, Lavallée JC, Potvin A, Szatmari P, Maziade M (1997) Clinical and methodological factors related to reliability of the best-estimate diagnostic procedure. Am J Psychiatry 154:1726-1733 (Pubitemid 27516591)
49. Maziade M, Rouleau N, Cellard C, Battaglia M, Paccalet T, Moreau I, Gagnon V, Gingras N, Marino C, Gilbert E, Roy MA, Merette C (2011) Young offspring at genetic risk of adult psychoses: the form of the trajectory of IQ or memory may orient to the right dysfunction at the right time. PLoS ONE 6:e19153
50. Slick DJ (2006) Psychometric in neuropsychological assessment. In: Strauss E, Sherman EMS, Spreen O (eds) A compendium of neuropsychological tests: Administration, norms, and commentary. Oxford University Press, USA
51. Endicott J, Spitzer RL, Fleiss JL, Cohen J (1976) The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry 33:766-771
52. Aas IH (2010) Global assessment of functioning (GAF): properties and frontier of current knowledge. Ann Gen Psychiatry 9:20
53. Pedersen G, Hagtvet KA, Karterud S (2007) Generalizability studies of the global assessment of functioning-split version. Compr Psychiatry 48:88-94 (Pubitemid 44826972)
54. Kay SR, Fiszbein A, Opler LA (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13:261-276 (Pubitemid 18039085)
55. Post RM, Roy-Byrne PP, Uhde TW (1988) Graphic representation of the life course of illness in patients with affective disorder. Am J Psychiatry 145:844-848
56. Gardner DM, Murphy AL, O'Donnell H, Centorrino F, Baldessarini RJ (2010) International consensus study of antipsychotic dosing. Am J Psychiatry 167:686-693
57. Marques TR, Arenovich T, Agid O, Sajeev G, Muthen B, Chen L, Kinon BJ, Kapur S (2011) The different trajectories of antipsychotic response: antipsychotics versus placebo. Psychol Med 41:1481-1488
58. Levine SZ, Lurie I, Kohn R, Levav I (2011) Trajectories of the course of schizophrenia: from progressive deterioration to amelioration over three decades. Schizophr Res 126:184-191
59. Butlen-Ducuing F, Haas M, Pani L, van Zwieten-Boot B, Broich K (2012) DSM-5 and clinical trials in psychiatry: challenges to come? Nat Rev Drug Discovery 11:583-584
60. Braff DL, Freedman R, Schork NJ, Gottesman I (2007) Deconstructing schizophrenia: an overview of the use of endophenotypes in order to understand a complex disorder. Schizophr Bull 33:21-32 (Pubitemid 46026257)
61. Levine SZ, Rabinowitz J, Case M, Ascher-Svanum H (2010) Treatment response trajectories and their antecedents in recentonset psychosis: a 2-year prospective study. J Clin Psychopharmacol 30:446-449
62. Stauffer V, Case M, Kollack-Walker S, Ascher-Svanum H, Ball T, Kapur S, Kinon BJ (2011) Trajectories of response to treatment with atypical antipsychotic medication in patients with schizophrenia pooled from 6 double-blind, randomized clinical trials. Schizophr Res 130:11-19
63. Derntl B, Habel U (2011) Deficits in social cognition: a marker for psychiatric disorders? Eur Arch Psychiatry Clin Neurosci 261(Suppl 2):S145-S149
64. Heaton RK, Gladsjo JA, Palmer BW, Kuck J, Marcotte TD, Jeste DV (2001) Stability and course of neuropsychological deficits in schizophrenia. Arch Gen Psychiatry 58:24-32 (Pubitemid 32057762)
65. Holthausen EA, Wiersma D, Sitskoorn MM, Hijman R, Dingemans PM, Schene AH, van den Bosch RJ (2002) Schizophrenic patients without neuropsychological deficits: subgroup, disease severity or cognitive compensation? Psychiatry Res 112:1-11
66. Cobia DJ, Csernansky JG, Wang L (2011) Cortical thickness in neuropsychologically near-normal schizophrenia. Schizophr Res 133:68-76
67. Albus M, Hubmann W, Mohr F, Hecht S, Hinterberger-Weber P, Seitz NN, Kuchenhoff H (2006) Neurocognitive functioning in patients with first-episode schizophrenia : results of a prospective 5-year follow-up study. Eur Arch Psychiatry Clin Neurosci 256:442-451 (Pubitemid 44584061)
68. Blishen BR, Carroll WK, Moore C (1987) The 1981 socioeconomic index for occupations in Canada. Can Rev Soc Anthrop 24:465-488